Concepedia

Pharis Mohideen

PM

23

Publications

2K

Citations

18

H-Index

1991

Active since

Affiliations

George Washington University(Current)

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Massachusetts General Hospital

University of California San Diego

Pharis Mohideen is an author at George Washington University specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1991–2022

23

Publications

23

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

Svetlana E. Nikoulina, Theodore P. Ciaraldi, Sunder Mudaliar et al. · Diabetes · 2000 · 348 citations · Full text

Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial

Stephan Petersenn, Jochen Schopohl, Ariel Barkan et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 202 citations

Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study

Larry K. Kvols, Kjell E. Öberg, Thomas M. O’Dorisio et al. · Endocrine Related Cancer · 2012 · 194 citations · Full text

Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial

Julia Prague, Rachel Roberts, Alexander Comninos et al. · The Lancet · 2017 · 194 citations · Full text

Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24‐week, double‐blind, randomized trial

Changyu Pan, Wenying Yang, Jacqueline Barona et al. · Diabetic Medicine · 2008 · 167 citations · Full text

Rows per page

1–5 of 23